Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Childhood Solid Tumor, Protocol Specific 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia 1Blast Crisis 1

Interventions

Irinotecan 6Cyclophosphamide 3temsirolimus 2Sirolimus 2Filgrastim 2Carboplatin 2sargramostim 1reolysin 1irofulven 1cixutumumab 1aflibercept 1Vincristine 1Trabectedin 1Topotecan 1Tirapazamine 1Thiotepa 1Temozolomide 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Oxaliplatin 1Methylprednisolone 1Melphalan 1Immunologic Techniques 1Immunohistochemistry 1Gemcitabine 1Gefitinib 1Flow Cytometry 1Etoposide 1Enzyme-Linked Immunosorbent Assay 1Cyclosporine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Unspecified Childhood Solid Tumor, Protocol Specific × irofulven × Clear all
NCT00003370 2013-02-05

Irofulven in Treating Children With Recurrent or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
12 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡